NC
NewSquare Capital Portfolio holdings
AUM
$1.35B
1-Year Return
14.04%
This Quarter Return
-2.79%
1 Year Return
+14.04%
3 Year Return
+46.44%
5 Year Return
+85.69%
10 Year Return
+172.98%
AUM
$946M
AUM Growth
-$15.6M
(-1.6%)
Cap. Flow
+$28.8M
Cap. Flow
% of AUM
3.04%
Top 10 Holdings %
Top 10 Hldgs %
32.18%
Holding
958
New
88
Increased
156
Reduced
199
Closed
343
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 6.1% |
| 2 | Financials | 6.04% |
| 3 | Healthcare | 4.77% |
| 4 | Consumer Discretionary | 4.62% |
| 5 | Industrials | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Monster Beverage
MNST
$61B
| $19.2K | ﹤0.01% |
+363
| New | +$19.2K |
|
252
Charles Schwab
SCHW
$167B
| $18.6K | ﹤0.01% |
338
+234
| +225% | +$12.8K |
|
253
Newell Brands
NWL
$2.68B
| $18.5K | ﹤0.01% |
2,045
+1,999
| +4,346% | +$18.1K |
|
254
Global X S&P 500 Covered Call ETF
XYLD
$3.1B
| $18.1K | ﹤0.01% |
465
| – | – |
|
|
ATVI
255
DELISTED
Activision Blizzard Inc.
ATVI
| $18.1K | ﹤0.01% |
+193
| New | +$18.1K |
|
256
Sherwin-Williams
SHW
$92.9B
| $17.9K | ﹤0.01% |
+70
| New | +$17.9K |
|
257
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.22B
| $17.8K | ﹤0.01% |
1,060
| – | – |
|
258
Vanguard Mid-Cap Growth ETF
VOT
$17.5B
| $17.5K | ﹤0.01% |
90
| – | – |
|
259
Invesco NASDAQ Internet ETF
PNQI
$806M
| $17.5K | ﹤0.01% |
570
-1,310
| -70% | -$40.2K |
|
260
Wells Fargo
WFC
$253B
| $17.3K | ﹤0.01% |
424
+29
| +7% | +$1.19K |
|
261
Tyson Foods
TSN
$20B
| $17.2K | ﹤0.01% |
341
| – | – |
|
262
Schlumberger
SLB
$53.4B
| $17.1K | ﹤0.01% |
294
+279
| +1,860% | +$16.3K |
|
263
Genuine Parts
GPC
$19.4B
| $16.9K | ﹤0.01% |
117
| – | – |
|
264
FedEx
FDX
$53.7B
| $16.5K | ﹤0.01% |
62
+60
| +3,000% | +$15.9K |
|
265
Vanguard FTSE Europe ETF
VGK
$26.9B
| $16.5K | ﹤0.01% |
+284
| New | +$16.5K |
|
266
Fastenal
FAST
$55.1B
| $16.2K | ﹤0.01% |
+592
| New | +$16.2K |
|
267
Kite Realty
KRG
$5.11B
| $16.1K | ﹤0.01% |
751
| – | – |
|
268
Coca-Cola
KO
$292B
| $16K | ﹤0.01% |
285
+48
| +20% | +$2.69K |
|
269
Novartis
NVS
$251B
| $15.7K | ﹤0.01% |
154
+138
| +863% | +$14.1K |
|
270
Enterprise Products Partners
EPD
$68.6B
| $15.4K | ﹤0.01% |
562
-188
| -25% | -$5.15K |
|
271
Welltower
WELL
$112B
| $15.2K | ﹤0.01% |
185
+77
| +71% | +$6.31K |
|
272
Xylem
XYL
$34.2B
| $15.1K | ﹤0.01% |
166
| – | – |
|
273
Philip Morris
PM
$251B
| $15.1K | ﹤0.01% |
163
| – | – |
|
274
PPL Corp
PPL
$26.6B
| $14.8K | ﹤0.01% |
630
| – | – |
|
275
Albemarle
ALB
$9.6B
| $14.8K | ﹤0.01% |
87
+80
| +1,143% | +$13.6K |
|